Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for EBM Technologies's EV-to-EBIT or its related term are showing as below:
ROCO:8409'
s EV-to-EBIT Range Over the Past 10 Years
Min: -74.06 Med: -15.7 Max: 128.98
Current: 13.35
During the past 13 years, the highest EV-to-EBIT of EBM Technologies was 128.98. The lowest was -74.06. And the median was -15.70.
ROCO:8409's EV-to-EBIT is ranked better than 58.33% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 15.78
vs ROCO:8409: 13.35
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
EBM Technologies's Enterprise Value for the quarter that ended in Jun. 2026 was NT$559.6 Mil.
EBM Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$38.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBM Technologies EV-to-EBIT Related Terms
EBM Technologies EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for EBM Technologies's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:8409 vs VEEV, BTSG, HQY: EV-to-EBIT Comparison
For the Health Information Services subindustry, EBM Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EBM Technologies EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EBM Technologies's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where EBM Technologies's EV-to-EBIT falls into.
EBM Technologies's current Enterprise Value is NT$516.4 Mil.
EBM Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$38.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBM Technologies (ROCO:8409) has a EV-to-EBIT of 13.35 as of Aug. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EBM Technologies and its competitors. According to the industry distribution chart, EBM Technologies ranks #200 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 41.7%.
Is EBM Technologies' EV-to-EBIT too high?
EBM Technologies' current EV-to-EBIT is 13.35. The Healthcare Providers & Services industry median EV-to-EBIT is 15.78. EBM Technologies' value of 13.35 is 15.4% below this industry median. Based on the distribution chart, EBM Technologies ranks #200 out of 480 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, EBM Technologies has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EBM Technologies' EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, EBM Technologies ranks #200 out of 480 companies for EV-to-EBIT. This puts EBM Technologies in the upper half of its industry. The industry median EV-to-EBIT is 15.78. EBM Technologies' value of 13.35 is 15.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.78, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EBM Technologies's current EV-to-EBIT of 13.35 is 15.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EBM Technologies and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EBM Technologies's current EV-to-EBIT is 13.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EBM Technologies stock overvalued right now?
Based on GuruFocus' analysis, EBM Technologies (ROCO:8409) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$25.18, compared to a current price of NT$18.00 — trading 28.5% below its estimated fair value. The current EV-to-EBIT is 13.35 and 15.4% below the Healthcare Providers & Services industry median of 15.78. EBM Technologies' overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For EBM Technologies (ROCO:8409), the current EV-to-EBIT is 13.35 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EBM Technologies (ROCO:8409) Overvalued in 2026?
Based on GuruFocus' analysis, EBM Technologies stock appears to be undervalued.
The current stock price of NT$18.00 is trading 28.5% below its estimated GF Value™ of NT$25.18.
GuruFocus considers EBM Technologies to be Modestly Undervalued.
Key valuation signals for ROCO:8409:
EV-to-EBIT: 13.35
GF Value™: NT$25.18 vs. price of NT$18.00 (28.5% below fair value)
Industry Position: 15.4% below the Healthcare Providers & Services median (#200 of 480)
No single metric tells the full story. See the ROCO:8409 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.
67GF Score
Get the complete analysis for ROCO:8409
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:8409 has been successfully added to your 
